{"entity":{"id":"nct05797077","kind":"trial","name":"Postoperation Maintenance Therapy for Resectable Liver Metastases of Colorectal Cancer Guided by ctDNA","aka":[],"tldr":"A phase 3 trial of capecitabine in colorectal cancer, run by Sixth Affiliated Hospital, Sun Yat-sen University, now recruiting.","summary":"Postoperation Maintenance Therapy for Resectable Liver Metastases of Colorectal Cancer Guided by ctDNA is a phase 3, randomised interventional study registered as NCT05797077 by Sixth Affiliated Hospital, Sun Yat-sen University, with a registry enrolment figure of 346 participants, started 2023-02-20 and due to reach its primary completion in 2029-02-20. Interventions recorded: Colorectal resection surgery.; FOLFOX chemotherapy regimen; Capecitabine. Conditions listed: Colorectal Cancer; Liver Metastases; Circulating Tumor Cell; Cancer, Therapy-Related. Primary outcome: 3-years Progression Free Survival; 5-years Progression Free Survival. Colorectal eligibility wording from the registry: \"Patients with liver metastatic colorectal cancer who have undergone R0 resection based on MDT evaluation (including patients whose metastases have been treated with ablation achieving similar R0 resection effect);\". Sites: China. No results are recorded here; the registry entry is the source.","status":"recruiting","asOf":"2026-09-24","links":[{"label":"ClinicalTrials.gov NCT05797077","url":"https://clinicaltrials.gov/study/NCT05797077"}],"tags":["ctgov-ingest","colorectal-deep-dive"],"related":[],"cancers":["rectal-cancer","colon-cancer"],"sections":[],"technologies":["cytotoxic-chemotherapy","mrd-testing"],"targets":[],"drugs":["capecitabine"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT05797077","phase":"3","setting":"Postoperation Maintenance Therapy for Resectable Liver Metastases of Colorectal Cancer Guided by ctDNA: a Multicenter, Randomized, Controlled, Phase III Clinical Trial.","sponsor":"Sixth Affiliated Hospital, Sun Yat-sen University","enrolled":346,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct05797077/","neighbours":{"cancer":[{"id":"colon-cancer","kind":"cancer","name":"Colon cancer (adenocarcinoma of the colon)","route":"/cancers/colon-cancer/"},{"id":"rectal-cancer","kind":"cancer","name":"Rectal cancer","route":"/cancers/rectal-cancer/"}],"technology":[{"id":"cytotoxic-chemotherapy","kind":"technology","name":"Cytotoxic chemotherapy","route":"/technologies/cytotoxic-chemotherapy/"},{"id":"mrd-testing","kind":"technology","name":"MRD / molecular residual disease testing","route":"/technologies/mrd-testing/"}],"drug":[{"id":"capecitabine","kind":"drug","name":"Capecitabine","route":"/drugs/capecitabine/"}],"term":[{"id":"colorectal-trials-open-today","kind":"term","name":"Colorectal cancer trials open today (registry snapshot)","route":"/terms/colorectal-trials-open-today/"}]}}